Sealing The Deal: O'Melveny Nails Historic Buy For China's BGI

Law360, New York (April 30, 2013, 4:22 PM EDT) -- While most Americans were sitting down to a turkey dinner, a group of O'Melveny & Myers LLP attorneys spent their Thanksgiving holiday last November responding to a third-party offer that threatened to derail a historic acquisition by their client, Chinese genome sequencing company BGI-Shenzhen.

BGI had reached an agreement to acquire genome technology firm Complete Genomics Inc. for $117.6 million in September, the first-ever acquisition of a U.S. public company by a Chinese firm. But BGI's U.S. rival, Illumina Inc., made an unsolicited competing offer while...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.